A
$ Value
$0
Shares
235,000
Price
$0
Filed
Nov 3
Insider
Name
Gall Matthew
Title
Chief Financial Officer
CIK
0001816194
Roles
Officer
Transaction Details
Transaction Date
2025-11-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
235,000
Footnotes
The option was granted on November 3, 2025. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on November 3, 2026, and the remainder vesting in equal monthly installments thereafter, subject to continuous service.
Filing Info
Gall Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-19 | KLRS | A | $0 |
| 2025-11-03 | KLRS | A | $0 |
| 2025-08-29 | ITOS | U | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
Other Insiders at KLRS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| AKKARAJU SRINIVAS | $5.0M | — | 2025-12-18 |
|
Hagen Brett R
Chief Accounting Officer
|
— | $13K | 2026-03-20 |
|
Feinsod Matthew
Chief Medical Officer
|
— | — | 2026-03-19 |
|
Oxtoby Andrew
See Remarks
|
— | — | 2026-03-19 |
|
Gall Matthew
Chief Financial Officer
|
— | — | 2026-03-19 |